Dec 23, 2008 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. FDA has granted tentative approval for the Company's Abbreviated New Drug Application to market its generic version of AstraZeneca's antipsychotic agent Seroquel (Quetiapine Fumarate) Tablets, Eq. 25 mg base, 50 mg base, 100 mg base, 150 mg base, 200 mg base, 300 mg base and 400 mg base.
The details can be read here.
No comments:
Post a Comment